KOMISJA NADZORU FINANSOWEGO
Raport bieżący nr6/2019
Data sporządzenia: 2019-12-16
Skrócona nazwa emitenta
MILESTONE MEDICAL
Temat
Signing the Agreement with 3B Scientific to Distribute the CompuFlo Epidural Trainer Globally
Podstawa prawna
Art. 17 ust. 1 MAR - informacje poufne.
Treść raportu:
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”), today announced it received the signed agreement with 3B Scientific, the world’s leading supplier of didactic material for medical education to distribute the CompuFlo® Epidural Trainer (CompuFlo Trainer) globally. The Companies initially agreed to sell the CompuFlo Trainer in North, Central and select countries in South America. 3B Scientific, represented in over 100 countries worldwide was founded in 1948 in Hamburg, Germany and has grown to be the world's leading manufacturer of anatomical models and a global supplier of innovative and reliable medical simulators for basic, advanced and specialty skill training. The CompuFlo Trainer is an instructional instrument that uses Dynamic Pressure Sensing technology and objective intelligence to improve epidural placement by trainees. The instrument links trainee tactile feel with visual and audible confirmation of real-time pressure changes to verify the epidural space has been reached. For the first time, instructors, who previously depended on student feedback of their tactile feel during a procedure, are now empowered to empirically monitor needle movement. The CompuFlo Trainer features a visual display of pressure and fluid, as well as a corresponding audible tone for more precise feedback and student guidance. Procedure documentation is also generated to enhance educational discussion and monitor skill development. The Board of Directors of the Issuer believes its agreement with 3B Scientific is a game changer for anesthesia training. Pairing 3B Scientific’s advanced simulators with CompuFlo’s ability to measure pressure in real-time at the tip of a needle, removes the uncertainty and stress experienced by both trainees and instructors, and replaces it with an objective, collaborative training experience. The Board of Directors of the Company believes that its focus on the education market will position CompuFlo® as a new standard of care with the next generation of anesthesiologists and certified registered nurse anesthetists. The global agreement allows the Issuer to capitalize on international interest in the CompuFlo Trainer received at the Euroanesthesia 2019 and gives more anesthesia instructors the ultimate solution to accelerate the epidural procedure’s learning curve and trainee success decreasing dural puncture incidence. The study published in Regional Anesthesia shows on average 90 patient epidural procedures may be necessary to reach an adequate basic skill with traditional loss-of-resistance technique.
MESSAGE (ENGLISH VERSION)
MILESTONE MEDICAL INC
(pełna nazwa emitenta)
MILESTONE MEDICAL
(skrócona nazwa emitenta)(sektor wg. klasyfikacji GPW w W-wie)
NJ 07039.
(kod pocztowy)(miejscowość)
South Orange Avenue Livingston220
(ulica)(numer)
+11 973 535 2717+11 973 535 2829
(telefon)(fax)
(e-mail)(www)
27-5484393
(NIP)(REGON)
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
DataImię i NazwiskoStanowisko/FunkcjaPodpis
2019-12-16Joseph D'AgostinoChief Financial OfficerJoseph D'Agostino